Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Xiu-Peng Yang"'
Publikováno v:
AIMS Bioengineering, Vol 10, Iss 4, Pp 440-465 (2023)
Background: Myelodysplastic syndrome is a malignant clonal disorder of hematopoietic stem cells (HSC) with both myelodysplastic problems and hematopoietic disorders. The greatest risk factor for the development of MDS is advanced age, and aging caus
Externí odkaz:
https://doaj.org/article/a20716992bdd449e8157a9ad92452059
Autor:
De-Xiu, Wang, Yong-Gang, Xu, Yu, Du, Hong-Zhi, Wang, Liu, Li, Xiao-Mei, Hu, Xiu-Peng, Yang, Rou, Ma, Qing-Bing, Zhou
Publikováno v:
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan. 41(4)
To explore the relationship between the efficacy of realgar for the treatment of myelodysplastic syndromes with multilineage dysplasia (MDS-MLD) and arsenic concentration in the peripheral blood of patients.In this prospective study, a total of 50 MD
Publikováno v:
Chinese journal of integrative medicine. 23(9)
To measure the proportions of blood T cell subsets, Th1, Th2, Th17, Th22, and Treg cells, and other parameters in patients with chronic immune thrombocytopenia (CITP) before and after treatment with Yiqi Tongyang Decoction (, YTD) to explore T cell s
Publikováno v:
Leukemia & Lymphoma. 51:1550-1558
Tryptases are predominantly mast cell-specific serine proteases with pleiotropic biological activities. Recently, significant amounts of tryptases have been shown to be produced by myeloblasts in certain patients with acute myeloid leukemia (AML), bu
Publikováno v:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 34(1)
Autor:
Shuzhen S; National Hematological Medical Center of Traditional Chinese Medicine, Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China., Rou M, Xiaomei H, Xiao-Hong Y, Yong-Gang X, Hongzhi W, Xiu-Peng Y
Publikováno v:
Evidence-based complementary and alternative medicine : eCAM [Evid Based Complement Alternat Med] 2012; Vol. 2012, pp. 969476. Date of Electronic Publication: 2012 Oct 16.